CORTISOL; HYPERSECRETION

Clinical trials for CORTISOL; HYPERSECRETION explained in plain language.

Never miss a new study

Get alerted when new CORTISOL; HYPERSECRETION trials appear

Sign up with your email to follow new studies for CORTISOL; HYPERSECRETION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug tested to tame dangerous hormone flood

Disease control Completed

This study tested an investigational drug called SPI-62 to see if it could safely reduce the harmful excess cortisol caused by ACTH-dependent Cushing's syndrome. For 24 weeks, 26 adult participants received either the drug or a placebo, with an option to continue on the drug long…

Matched conditions: CORTISOL; HYPERSECRETION

Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control

Last updated Apr 02, 2026 05:11 UTC

CORTISOL; HYPERSECRETION

Get alerted when new CORTISOL; HYPERSECRETION trials appear

New drug tested to tame dangerous hormone flood